As of 11:42am ET
| -0.34 / -3.95%|
The 3 analysts offering 12-month price forecasts for MediciNova Inc have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 16.03. The median estimate represents a +117.65% increase from the last price of 8.27.
The current consensus among 3 polled investment analysts is to Buy stock in MediciNova Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.